ELOXX PHARMACEUTICALS, INC. (ELOX) Operating cash flow 2016–2025
ELOXX PHARMACEUTICALS, INC. (ELOX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.3MFY2025 · since FY2016: -$1.9M → -$6.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.3M | -34.2% |
| FY2024 | -$4.7M | +67.1% |
| FY2023 | -$14.3M | +55.0% |
| FY2022 | -$31.8M | +9.0% |
| FY2021 | -$35.0M | -24.3% |
| FY2020 | -$28.2M | +28.5% |
| FY2019 | -$39.4M | -25.6% |
| FY2018 | -$31.4M | -96.8% |
| FY2017 | -$15.9M | -727.7% |
| FY2016 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ELOX financial trends
ELOX RevenueELOX Net incomeELOX Net marginELOX Gross profitELOX Gross marginELOX Operating incomeELOX Operating marginELOX Free cash flowELOX Capital expendituresELOX Return on equityELOX Stock buybacksELOX Dividends paidELOX Total assetsELOX Total liabilitiesELOX Shareholders’ equityELOX overview →